Sort By:

Migraine Relief Intranasal Spray

Rochester Clinical Research is conducting a study to evaluate the efficacy of the investigational nasal powder for the treatment of an acute migraine. The purpose of the study is to evaluate a new delivery system for an established migraine medication called dihydroergotamine, or DHE. The study will be a single intranasal dose and aims to give migraine symptom relief within two hours of taking the medication .

View Trial Details
Ages 18 - 65
Compensation* $300*
Study Topics Migraines

*Compensation for time and travel may be available to those who qualify.